Diabetic Retinopathy: all 791 studies
Page 6 of 8. Open to participants first (139), then studies with results posted, then the rest; newest registration first within each.
- Routine Clinical Practice for Use of Intravitreal Aflibercept Treatment in Patients With Diabetic Macular EdemaCompletedNCT02924311
- Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic RetinopathyStatus unknownNCT02911311Not applicable
- Correlation Between Macular Ischemia and Peripheral Ischemia in Patients With DiabetesCompletedNCT02876744
- A Systematic Study of Retinal Structure and Function in Diabetic Macular OedemaCompletedNCT02876393
- Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic RetinopathyTerminatedNCT02875704
- CPAP Effect on the Progression of Diabetic Retinopathy in Patients With Sleep ApneaCompletedNCT02874313Phase 4
- A Comparison of the Checkup Vision Assessment System to Standard Vision Assessment ToolsStatus unknownNCT02871817
- Diabetic Retinopathy Screening in Private PracticeCompletedNCT02866734Not applicable
- Intravitreal Injection of Ranibizumab Versus Sham Before Vitrectomy in Patients With Proliferative Diabetic RetinopathyCompletedNCT02857491Not applicable
- Adaptive Optics for Ophthalmic TechnologiesTerminatedNCT02826655Not applicable
- Pattern Scanning Laser Pan-retinal Photocoagulation in Proliferative Diabetic RetinopathyCompletedNCT02816073Not applicable
- Aflibercept for Retinopathy in the Real WorldWithdrawnNCT02812030
- Ocular Discomfort Assessment After Intravitreal InjectionsCompletedNCT02806830Not applicable
- A Study Assessing Efficacy and Safety of OC-10X in the Treatment of PDRTerminatedNCT02735369Phase 2
- PRP vs Bevacizumab for PDR TreatmentCompletedNCT02705274Phase 2/3
- Applicability of the Acai Fruit (Euterpe Oleracea) Dye for Chromovitrectomy in HumansCompletedNCT02691429Not applicable
- Pediatric Type 1 Diabetes and RetinopathyCompletedNCT02691312
- The Relationship Between Advanced Glycation Endproducts and DiabetesCompletedNCT02662010
- Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular GlaucomaCompletedNCT02647515Phase 4
- PASCAL Laser Platform Produces Less Pain Responses Compared To Conventional Laser SystemCompletedNCT02645383Not applicable
- International Consortium Investigating Early Vitrectomy in Diabetic Macular Edema PatientsCompletedNCT02639507
- Imaging Parameters and DME Treatment ResponseCompletedNCT02637245
- Evaluation of Treatment of High riSk proLiferative Diabetic retinopathY With Intravitreal Aflibercept injectioNStatus unknownNCT02630277Phase 2
- Effect of Gastric Bypass Surgery on Diabetes Status and Microvascular Complications in Obese Type 2 Diabetic PatientsCompletedNCT02625649
- Investigating the Structural and Functional Changes to the Retina Following PRP in Diabetic Retinopathy PatientsCompletedNCT02621580Not applicable
- Preoperative Bevacizumab and Ziv-Aflibercept Administration in PDR Subjects Undergoing PPVCompletedNCT02590094Not applicable
- CLEAR SIGHT: A Trial of Non-Mydriatic Ultra-Widefield Retinal Imaging to Screen for Diabetic Eye DiseaseCompletedNCT02579837Not applicable
- Comparison of Retinal Oxygenation and Retinal Vessel Diameters in Healthy Subjects and Patients With Diabetic Retinopathy or Retinal Vein Occlusion Between DVA and OxymapCompletedNCT02521116Not applicable
- Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF InjectionStatus unknownNCT02486484Phase 2
- Study of Topical Ocular PAN-90806 in PDRCompletedNCT02475109Phase 1
- Efficacy of Higher Cutting Rate in Microincision Vitrectomy for Proliferative Diabetic RetinopathyCompletedNCT02464800
- Photobiomodulation for the Treatment of Diabetic Macular EdemaCompletedNCT02457975Early Phase 1
- 25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical TrialStatus unknownNCT02447185Phase 3
- A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic RetinopathyCompletedNCT02435862Phase 2
- Laser Therapy Combined With Intravitreal Aflibercept vs Intravitreal Aflibercept Monotherapy (LADAMO)CompletedNCT02432547Phase 4
- Microalbuminuria as a Cardiovascular Risk Factor (PRECISED Substudy)Status unknownNCT02409511
- Clinical Evaluation of Noninvasive OCT Angiography Using a Zeiss OCT Prototype to Compare to Fluorescein AngiographyCompletedNCT02391558
- Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic RetinopathyStatus unknownNCT02388984Phase 3
- OcuStem Nutritional Supplement in Diabetic Patients With Mild to Moderate Non-proliferative RetinopathyStatus unknownNCT02353923Not applicable
- Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME)WithdrawnNCT02349516Phase 2
- Conjunctival Flora Patterns After Serial Intravitreal Injections in Diabetic PatientsStatus unknownNCT02337972Not applicable
- A Pilot Project to Assess the Impact of Diabetes Education During Ophthalmology VisitsCompletedNCT02334137
- OCT Biomarkers for Diabetic RetinopathyActive, not recruitingNCT02330042
- 25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in ChinaStatus unknownNCT02328118Phase 2/3
- Evaluation of Progression of Diabetic Retinopathy With Rapid Correction of HyperglycemiaCompletedNCT02326259
- Eye Screening in German Secondary Diabetes Care CentersCompletedNCT02311504
- Panretinal Photo-stimulation in Proliferative Diabetic RetinopathyWithdrawnNCT02309502Not applicable
- Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin TherapyCompletedNCT02307110Not applicable
- Effect of a Self-care Intervention on Depression in People With Age-related Macular Degeneration or Diabetic RetinopathyCompletedNCT02261194Not applicable
- PRELIMINARY EVALUATION OF PHARMACOLOGICAL LOWERING OF AGEsCompletedNCT02249897Phase 4
- The Effect of Hyperbaric Chamber Treatment on Patients With Diabetic RetinopathyStatus unknownNCT02235935
- Prevalence of DIAbetic RETinopathy and Impact of Genetic Factors in the Development of Diabetic Retinopathy of Patients With Type 1 and 2 Diabetes Mellitus in SlovaKiaCompletedNCT02232503
- Efficacy of Dorzolamide as an Adjuvant After Focal Photocoagulation in Clinically Significant Macular EdemaStatus unknownNCT02227745
- Contrast Sensitivity and Diabetic Macular EdemaCompletedNCT02217306
- Noctura400 Treatment for Diabetic Retinopathy (CANDLE)TerminatedNCT02207712Not applicable
- Smartphone-based OphthalmoscopyCompletedNCT02177747Not applicable
- The Individually Marked Panretinal lasEr phoTokoagUlation for Proliferative Diabetic Retinopathy Study - DETECTCompletedNCT02157350Phase 3
- Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy.CompletedNCT02151695Phase 2
- Resistance to Antibiotics in Patients Receiving Eye InjectionsCompletedNCT02126423
- Collaborative Care for Depression and Diabetic Retinopathy in African AmericansCompletedNCT02121340Not applicable
- Vascular Reparative Mechanism in DiabetesActive, not recruitingNCT02119689
- Restoration of Retinal Vascular Responses in Type 1 Diabetic PatientsCompletedNCT02099981Phase 1
- Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular EdemaCompletedNCT02096874Phase 4
- Study of Effectiveness of Telemedicine in Identifying Diabetic Retinopathy CasesCompletedNCT02085681Not applicable
- Monocyte Chemoattractant Protein-1 2518A/G PolymorphismCompletedNCT02077127
- Analysis of Aqueous and Vitreous HumorStatus unknownNCT02067013Phase 2
- Reading Center - Occurence of Diabetic Macular Edema in Patients With Diabetes Mellitus in Slovak RepublicStatus unknownNCT02063321
- Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic RetinopathyCompletedNCT02062034Phase 2
- Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With NormoalbuminuriaCompletedNCT02040441Phase 2/3
- PASCAL Laser Versus ETDRS Laser Associated With Intravitreal Ranibizumab (IVR) Versus Only IVR for Proliferative Diabetic RetinopathyStatus unknownNCT02005432Phase 4
- Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic RetinopathyCompletedNCT01976923Phase 3
- Evaluation of the Retina of Subjects Without Diabetes Mellitus and Subjects With Diabetes Mellitus Without Diabetic Retinopathy Using Optical Coherence TomographyCompletedNCT01946997
- Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy.CompletedNCT01941329Phase 2/3
- Diabetes PRP and OCTCompletedNCT01928550
- Effects of Fenofibrate on Endothelial Progenitor Cells in DiabetesCompletedNCT01927315Phase 4
- Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic RetinopathyStatus unknownNCT01921192Phase 4
- Vitreous Levels of Cysteine-rich 61 in Patients With Proliferative Diabetic RetinopathyCompletedNCT01920984Not applicable
- The Use of Alpha Lipoic Acid for the Treatment and Prevention of Diabetic RetinopathyTerminatedNCT01880372Not applicable
- Living Successfully With Chronic Eye DiseasesStatus unknownNCT01879501Not applicable
- Serum and Intraocular Levels of Erythropoietin and VEGF in Type 2 Diabetes Patients With Proliferative RetinopathyCompletedNCT01871207
- Phase I Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10XCompletedNCT01869933Phase 1
- a Trial of Using SMS Reminder Among Diabetic Retinopathy Patients in Rural ChinaCompletedNCT01837121Not applicable
- Reduction of Foveal Sensitivity in Eyes With Diabetic Macular EdemaCompletedNCT01824862
- Use of Intravitreal Ranibizumab in the Treatment of Vitreous HemorrhageStatus unknownNCT01824043Phase 4
- Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T StudyCompletedNCT01813773Phase 2/3
- Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal PhotographyStatus unknownNCT01790945
- Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular OedemaCompletedNCT01787669Phase 2
- Incidence of Retinopathy and Associated Risk Factors in Children and Young Adults With Type 1 Diabetes in DenmarkCompletedNCT01785667
- Squalamine for the Treatment in Proliferative Diabetic RetinopathyCompletedNCT01769183Phase 2
- Comparison of Changes of Inflammatory Proteins in Aqueous Humour of Subjects Treated With Avastin vs LucentisCompletedNCT01760746
- Safety and Effectiveness Study of 532nm Laser Subthreshold Panretinal Photocoagulation for Severe NPDRStatus unknownNCT01759121Not applicable
- Comparison of Small-gauge Vitrectomy and Conventional Vitrectomy for Proliferative Diabetic RetinopathyCompletedNCT01758757Not applicable
- Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic RetinopathyCompletedNCT01746563Phase 1/2
- Overcoming Barriers in Vision Care Utilization of African Americans With DiabetesCompletedNCT01744132Not applicable
- Uptake of Comprehensive Eye Examination TrialCompletedNCT01743781Not applicable
- Safety and Efficacy of Low-Fluence PRP for PDRTerminatedNCT01737957Not applicable
- Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for RetinopathyActive, not recruitingNCT01736059Phase 1
- Diabetic Retinopathy And the Myvisiontrack® (DRAMA) StudyCompletedNCT01728883
- Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic RetinopathyCompletedNCT01726075Phase 2/3
- Intravitreal Bevacizumab for Proliferative Diabetic RetinopathyCompletedNCT01724385Phase 4